Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	2.34
Equity-to-Asset	0.43
Debt-to-Equity	0.04
Debt-to-EBITDA	0.4
Interest Coverage	0.94
Piotroski F-Score	N/A/9	0 1 2 3 4 5 6 7 8 9
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	Future 3-5Y EPS without NRI Growth Rate Estimate	154.22
	Future 3-5Y Total Revenue Growth Rate Estimate	7.55

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	84.81
	9-Day RSI	67.38
	14-Day RSI	56.76
	6-1 Month Momentum %	13.03
	12-1 Month Momentum %	27.63

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.22
	Quick Ratio	0.74
	Cash Ratio	0.12
	Days Inventory	184.08
	Days Sales Outstanding	94.51
	Days Payable	105.53

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.16
	Dividend Payout Ratio	0.66
	Forward Dividend Yield %	1.16
	5-Year Yield-on-Cost %	1.16

Profitability Rank

3/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	45.23
	Operating Margin %	2.49
	Net Margin %	-0.03
	FCF Margin %	-1.39
	ROE %	-0.03
	ROA %	-0.02
	ROIC %	1.32
	ROC (Joel Greenblatt) %	9.73
	ROCE %	1.84
	Years of Profitability over Past 10-Year	2

GF Value Rank

	Name	Current	Vs Industry		Vs History
	Forward PE Ratio	12.51
	PE Ratio without NRI	56.72
	PS Ratio	1.86
	PB Ratio	2.28
	Price-to-Operating-Cash-Flow	37.7
	EV-to-EBIT	74.77
	EV-to-Forward-EBIT	11.32
	EV-to-EBITDA	23.9
	EV-to-Forward-EBITDA	8.58
	EV-to-Revenue	1.78
	EV-to-Forward-Revenue	1.59
	EV-to-FCF	-132.7
	Earnings Yield (Greenblatt) %	1.34
	FCF Yield %	-0.75

Financials (Next Earnings Date:2025-03-13 Est.)

Annual Quarterly TTM

SDZNY's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

No Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

No Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

No Enough Data

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

No Enough Data

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with OTCPK:SDZNY

No Available Data

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016

Sandoz Group AG Executives

Details

GF Value

SDZNY

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 2 Severe warning signs with SDZNY. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil $)	10,111
	EPS (TTM) ($)	-0.018
	Beta	0
	Volatility %	31.85
	14-Day RSI	56.76
	14-Day ATR ($)	0.889684
	20-Day SMA ($)	41.3445
	12-1 Month Momentum %	27.63
	52-Week Range ($)	27.79 - 46.8
	Shares Outstanding (Mil)	438.93

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	9999
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Sandoz Group AG Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Sandoz Group AG Stock Events

Financials Calendars

	Event	Date	Price($)
No Event Data

Sandoz Group AG Frequently Asked Questions

What is Sandoz Group AG(SDZNY)'s stock price today?

The current price of SDZNY is $42.65. The 52 week high of SDZNY is $46.80 and 52 week low is $27.79.

When is next earnings date of Sandoz Group AG(SDZNY)?

The next earnings date of Sandoz Group AG(SDZNY) is 2025-03-13 Est..

Does Sandoz Group AG(SDZNY) pay dividends? If so, how much?

The Dividend Yield % of Sandoz Group AG(SDZNY) is 1.16% (As of Today), Highest Dividend Payout Ratio of Sandoz Group AG(SDZNY) was 0.66. The lowest was 0. And the median was 0. The Forward Dividend Yield % of Sandoz Group AG(SDZNY) is 1.16%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
No Press Release

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.